Medindia

X

Reportlinker Adds The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

Thursday, January 28, 2010 Press Release J E 4
Advertisement


NEW YORK, Jan. 27 Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

http://www.reportlinker.com/p0174567/The-Future-of-the-In-Vitro-Diagnostics-Market-to-2016---Increasing-Diagnostic-Procedures-Drive-Demand.html

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

Summary

GBI Research's new report, "The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand" provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.

- Global Market size and company share data for seven In-Vitro Diagnostics market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.

- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.

- Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.

- Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the In-Vitro Diagnostics market landscape? - Identify, understand and capitalize

- Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures Introduction and Overview 11

2.1 In-Vitro Diagnostics Overview 11

3 Global IVD Market: Market Characterization 12

3.1 Global IVD Market, Revenues ($m), 2002 - 2009 12

3.2 Global IVD Market, Revenue Forecasts ($m), 2009 - 2016 13

3.3 Global IVD Market, Key Company Shares (%), 2008 14

3.4 Global In-vitro Devices, Key Market Trends 15

3.4.1 Entry of In Diagnostic Imaging Players Into In Vitro Diagnostics Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines 15

3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the IVD Sector to Fuel Innovation 16

3.4.3 Consolidation of Laboratories across the World 16

3.5 Global In Vitro Diagnostics: Key Technology Trends 17

3.5.1 Emerging technologies for cutting lab costs 17

3.5.2 New Technologies Improve Speed and Accuracy 18

3.6 Global In-vitro Devices, Market Drivers 20

3.6.1 Economic Market Drivers 20

3.6.2 Technology Market Drivers 22

3.6.3 Regulatory Market Drivers 22

3.6.4 Social Market Drivers 22

3.7 In-vitro Devices, Market Restraints 23

3.7.1 Economic Market Restraints 23

3.7.2 Social Market Restraints 24

4 Global IVD Market: Market Category Analysis and Forecasts 25

4.1 Clinical Chemistry Market: Market Characterization 25

4.1.1 Global Clinical Chemistry Market, Revenues ($m), 2002-2009 25

4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009-2016 26

4.1.3 Global Clinical Chemistry Market, Key Company Shares (%), 2008 27

4.1.4 Clinical Chemistry Market: Market Drivers 28

4.1.5 Clinical Chemistry Market: Market Restraints 29

4.2 Immuno Chemistry Market: Market Characterization 30

4.2.1 Global Immuno Chemistry Market, Revenues ($m), 2002 - 2009 30

4.2.2 Global Immuno Chemistry Market, Revenue Forecasts ($m), 2009 - 2016 31

4.2.3 Global Immuno Chemistry Market, Key Company Shares (%), 2008 32

4.2.4 Immuno Chemistry Market: Market Drivers 33

4.2.5 Immuno Chemistry Market: Market Restraints 35

4.3 Haematology Market: Market Characterization 36

4.3.1 Global Haematology Market, Revenues ($m), 2002 - 2009 36

4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 - 2016 37

4.3.3 Global Haematology Market, Key Company Shares (%), 2008 38

4.3.4 Haematology Market: Market Drivers 39

4.3.5 Haematology Market: Market Restraints 40

4.4 Histology and Cytology Market: Market Characterization 41

4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 - 2009 41

4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 - 2016 42

4.4.3 Global Histology and Cytology Market, Key Company Shares (%), 2008 43

4.4.4 Histology and Cytology Market: Market Drivers 44

4.4.5 Histology and Cytology Market: Market Restraints 45

4.5 Microbiology Culture Market: Market Characterization 46

4.5.1 Global Microbiology Culture Market, Revenues ($m), 2002 - 2009 46

4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 - 2016 47

4.5.3 Global Microbiology Culture Market, Key Company Shares (%), 2008 48

4.5.4 Global Microbiology Culture Market: Market Drivers 49

4.5.5 Global Market Restraints Microbiology Culture Market: Market Restraints 50

4.6 Infectious Immunology Market: Market Characterization 51

4.6.1 Global Infectious Immunology Market, Revenues ($m), 2002 - 2009 51

4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 - 2016 52

4.6.3 Global Infectious Immunology Market, Key Company Shares (%), 2008 53

4.6.4 Global Infectious Immunology Market: Market Drivers 53

4.6.5 Global Infectious Immunology Market: Market Restraints 54

4.7 Genetic Testing Market: Market Characterization 55

4.7.1 Global Genetic Testing Market, Revenues ($m), 2002 - 2009 55

4.7.2 Global Genetic Testing Market, Key Company Shares (%), 2008 57

4.7.3 Global Genetic Testing Market: Market Drivers 58

4.7.4 Global Genetic Testing Market: Market Restraints 59

5 Global IVD Market: Country Analysis and Forecasts 61

5.1 Global IVD Market: Geographic Trends Analysis 61

5.2 Market Characterization, North America, 2002 - 2016 62

5.2.1 The US IVD Market, Revenues ($m), 2002 - 2009 62

5.2.2 The US IVD Market, Revenues ($m), 2009 - 2016 63

5.2.3 Canada IVD Market, Revenues ($m), 2002 - 2009 64

5.2.4 North America IVD Market, Market Drivers 66

5.2.5 North America IVD Market, Market Restraints 66

5.3 Market Characterization, Europe, 2002 - 2016 67

5.3.1 The UK IVD Market, Revenues ($m), 2002 - 2009 67

5.3.2 The UK IVD Market, Revenues ($m), 2009 - 2016 68

5.3.3 Germany IVD Market, Revenues ($m), 2002 - 2009 69

5.3.4 Germany IVD Market, Revenues ($m), 2009 - 2016 70

5.3.5 France IVD Market, Revenues ($m), 2002 - 2009 71

5.3.6 France IVD Market, Revenues ($m), 2009 - 2016 73

5.3.7 Italy IVD Market, Revenues ($m), 2002 - 2009 74

5.3.8 Italy IVD Market, Revenues ($m), 2009 - 2016 75

5.3.9 Spain IVD Market, Revenues ($m), 2002 - 2009 76

5.3.10 Spain IVD Market, Revenues ($m), 2009 - 2016 77

5.3.11 Belgium IVD Market, Revenues ($m), 2002 - 2009 78

5.3.12 Belgium IVD Market, Revenues ($m), 2009 - 2016 79

5.3.13 The Netherlands IVD Market, Revenues ($m), 2002 - 2009 80

5.3.14 The Netherlands IVD Market, Revenues ($m), 2009 - 2016 81

5.3.15 Europe IVD Market, Market Drivers 81

5.3.16 Europe IVD Market, Market Restraints 82

5.4 Market Characterization, Asia Pacific, 2002 - 2016 83

5.4.1 Japan IVD Market, Revenues ($m), 2002 - 2009 83

5.4.2 Japan IVD Market, Revenues ($m), 2009 - 2016 84

5.4.3 China IVD Market, Revenues ($m), 2002 - 2009 85

5.4.4 China IVD Market, Revenues ($m), 2009 - 2016 86

5.4.5 India IVD Market, Revenues ($m), 2002 - 2009 87

5.4.6 India IVD Market, Revenues ($m), 2009 - 2016 88

5.4.7 Australia IVD Market, Revenues ($m), 2002 - 2009 90

5.4.8 Australia IVD Market, Revenues ($m), 2009 - 2016 91

5.4.9 Taiwan IVD Market, Revenues ($m), 2002 - 2009 92

5.4.10 Taiwan IVD Market, Revenues ($m), 2009 - 2016 93

5.4.11 Republic of Korea IVD Market, Revenues ($m), 2002 - 2009 94

5.4.12 Republic of Korea IVD Market, Revenues ($m), 2009 - 2016 95

5.4.13 Asia Pacific IVD Market, Market Drivers 96

5.4.14 Asia Pacific IVD Market, Market Restraints 96

5.5 Market Characterization, South and Central America, 2002 - 2016 97

5.5.1 Brazil IVD Market, Revenues ($m), 2002 - 2009 97

5.5.2 Brazil IVD Market, Revenues ($m), 2009 - 2016 98

5.5.3 Argentina IVD Market, Revenues ($m), 2002 - 2009 99

5.5.4 Argentina IVD Market, Revenues ($m), 2009 - 2016 100

5.5.5 Mexico IVD Market, Revenues ($m), 2002 - 2009 101

5.5.6 Mexico IVD Market, Revenues ($m), 2009 - 2016 102

5.5.7 South and Central America IVD Market, Market Drivers 103

5.5.8 South and Central America IVD Market, Market Restraints 103

5.6 Market Characterization, Middle East and Africa, 2002 - 2016 104

5.6.1 Israel IVD Market, Revenues ($m), 2002 - 2009 104

5.6.2 Israel IVD Market, Revenues ($m), 2009 - 2016 105

5.6.3 South Africa IVD Market, Revenues ($m), 2002 - 2009 106

5.6.4 South Africa IVD Market, Revenues ($m), 2009 - 2016 107

5.6.5 Middle East and Africa IVD Market, Market Drivers 108

5.6.6 Middle East and Africa IVD Market, Market Restraints 108

6 Global IVD Market: Strategic Competitive Assessment 109

6.1 Key Market Participants 109

6.1.1 F. Hoffmann-La Roche Ltd 109

6.1.2 Siemens Medical Solutions USA, Inc. 111

6.1.3 Abbott Laboratories 113

6.1.4 Beckman Coulter, Inc. 115

6.1.5 bioMerieux Sa 117

6.1.6 Ortho-Clinical Diagnostics 118

6.1.7 Becton, Dickinson and Company 119

6.1.8 Bio-Rad Laboratories, Inc. 120

6.1.9 Inverness Medical Innovations, Inc 121

7 Global IVD Market: Product Pipeline Analysis 124

7.1 Pipeline Products Analysis by Category 124

7.1.1 Pipeline Products Analysis: Immuno Chemistry Market 125

7.1.2 Pipeline Products Analysis: Infectious Immunology 126

7.2 Key Pipeline Products Currently Undergoing Development 126

7.2.1 Clinical Chemistry Pipeline Products 126

7.2.2 Genetic Testing 126

7.2.3 Haematology 127

7.2.4 Immunochemistry 128

7.2.5 Infectious Immunology 129

7.2.6 Microbiology Culture 130

7.2.7 Histology and Cytology 130

8 Global IVD Market: Consolidation Landscape 131

8.1 Deals by Type, 2006 - 2009 131

8.2 Deals by Value and Volume, 2006 - 2009 132

8.3 List of Deals in 2009 132

8.4 Top 10 Acquisitions By Value, 2009 135

8.4.1 Agilent Technologies Receives Shareholders Approval To Acquire Varian 135

8.4.2 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 135

8.4.3 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher 135

8.4.4 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S. 136

8.4.5 Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital 136

8.4.6 Becton, Dickinson and Company Completes Acquisition Of HandyLab 136

8.4.7 Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 137

8.4.8 Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 137

8.4.9 Gen-Probe Acquires Tepnel Life Sciences 137

9 Appendix 139

9.1 Definitions 139

9.1.1 Clinical Chemistry 139

9.1.2 Immunochemistry Test Reagents 140

9.1.3 Haematology 141

9.1.4 Histology And Cytology 142

9.1.5 Microbiology Culture 143

9.1.6 Infectious Immunology 143

9.1.7 Genetic Testing 144

9.2 Acronyms 144

9.3 Methodology 144

9.3.1 Secondary Research 145

9.3.2 Primary Research 145

9.3.3 Models 146

9.3.4 Forecasts 146

9.3.5 Expert Panels 146

9.4 Contact Us 146

9.5 Disclaimer 147

1.1 List of Tables

Table 1: IVD Market, Global, Revenue ($m), 2002-2009 12

Table 2: IVD Market, Global, Revenue ($m), 2009-2016 13

Table 3: IVD Market, Global, Company Share ($m), 2008 14

Table 4: Clinical Chemistry Market, Global, Revenues ($m), 2002-2009 25

Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009-2016 26

Table 6: Clinical Chemistry Market, Global, Company Share ($m), 2008 27

Table 7: Clinical Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002-2016 28

Table 8: Immuno Chemistry Market, Global, Revenues ($m), 2002-2009 30

Table 9: Immuno Chemistry Market, Global, Revenue ($m), 2009-2016 32

Table 10: Immuno Chemistry Market, Global, Company Share ($m),2008 33

Table 11: Immuno Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002-2016 34

Table 12: Haematology Market, Global, Revenues ($m), 2002-2009 36

Table 13: Haematology Market, Global, Revenue ($m), 2009-2016 37

Table 14: Haematology Market, Global, Company Share ($m),2008 38

Table 15: Haematology Market, Comparison of Top 10 Countries By Revenue, 2002-2016 39

Table 16: Histology and Cytology Market, Global, Revenue ($m), 2002-2009 41

Table 17: Histology and Cytology Market, Global, Revenue ($m), 2009-2016 42

Table 18: Histology and Cytology Market, Global, Company Share ($m),2008 43

Table 19: Histology and Cytology Market, Comparison of Top 10 Countries By Revenue,

2002-2016 44

Table 20: Microbiology Culture Market, Global, Revenue ($m), 2002-2009 46

Table 21: Microbiology Culture Market, Global, Revenue ($m), 2009-2016 47

Table 22: Microbiology Culture Market, Global, Company Share ($m),2008 48

Table 23: Microbiology Culture Market, Comparison of Top 10 Countries By Revenue,

2002-2016 49

Table 24: Infectious Immunology Market, Global, Revenue ($m), 2002-2009 51

Table 25: Infectious Immunology Market, Global, Revenue ($m), 2009-2016 52

Table 26: Infectious Immunology Market, Global, Company Share ($m),2008 53

Table 27: Genetic Testing Market, Global, Revenue ($m), 2002-2009 55

Table 28: Genetic Testing Market, Global, Revenue ($m), 2009-2016 56

Table 29: Global Genetic Testing Market, Global, Company Share ($m),2008 57

Table 30: Genetic Testing Market, Comparison of Top 10 Countries By Revenue, 2002-2016 58

Table 31: IVD Market, US, Revenue ($m), 2002-2009 62

Table 32: IVD Market, US, Revenue ($m), 2009-2016 63

Table 33: IVD Market, Canada, Revenue ($m), 2002-2009 64

Table 34: IVD Market, Canada, Revenue ($m), 2009-2016 65

Table 35: IVD Market, The UK, Revenue ($m), 2002-2009 67

Table 36: IVD Market, The UK, Revenue ($m), 2009-2016 68

Table 37: IVD Market, Germany, Revenue ($m), 2002-2009 69

Table 38: IVD Market, Germany, Revenue ($m), 2009-2016 70

Table 39: IVD Market, France, Revenue ($m), 2002-2009 72

Table 40: IVD Market, France, Revenue ($m), 2009-2016 73

Table 41: IVD Market, Italy, Revenue ($m), 2002-2009 74

Table 42: IVD Market, Italy, Revenue ($m), 2009-2016 75

Table 43: IVD Market, Spain, Revenue ($m), 2002-2009 76

Table 44: IVD Market, Spain, Revenue ($m), 2009-2016 77

Table 45: IVD Market, Belgium, Revenue ($m), 2002-2009 78

Table 46: IVD Market, Belgium, Revenue ($m), 2009-2016 79

Table 47: IVD Market, The Netherlands, Revenue ($m), 2002-2009 80

Table 48: IVD Market, The Netherlands, Revenue ($m), 2009-2016 81

Table 49: IVD Market, Japan, Revenue ($m), 2002-2009 83

Table 50: IVD Market, Japan, Revenue ($m), 2009-2016 84

Table 51: IVD Market, China, Revenue ($m), 2002-2009 85

Table 52: IVD Market, China, Revenue ($m), 2009-2016 86

Table 53: IVD Market, India, Revenue ($m), 2002-2009 88

Table 54: IVD Market, India, Revenue ($m), 2002-2009 89

Table 55: IVD Market, Australia, Revenue ($m), 2002-2009 90

Table 56: IVD Market, Australia, Revenue ($m), 2009-2016 91

Table 57: IVD Market, Taiwan, Revenue ($m), 2002-2009 92

Table 58: IVD Market, Taiwan, Revenue ($m), 2009-2016 93

Table 59: IVD Market, Republic of Korea, Revenue ($m), 2002-2009 94

Table 60: IVD Market, Republic of Korea, Revenue ($m), 2009-2016 95

Table 61: IVD Market, Brazil, Revenue ($m), 2002-2009 97

Table 62: IVD Market, Brazil, Revenue ($m), 2009-2016 98

Table 63: IVD Market, Argentina, Revenue ($m), 2002-2009 99

Table 64: IVD Market, Argentina, Revenue ($m), 2009-2016 100

Table 65: IVD Market, Mexico, Revenue ($m), 2002-2009 101

Table 66: IVD Market, Mexico, Revenue ($m), 2009-2016 102

Table 67: IVD Market, Israel, Revenue ($m), 2002-2009 104

Table 68: IVD Market, Israel, Revenue ($m), 2009-2016 105

Table 69: IVD Market, South Africa, Revenue ($m), 2002-2009 106

Table 70: IVD Market, South Africa, Revenue ($m), 2009-2016 107

Table 71: Roche's Merger and Acquisitions, IVD Market, 2007-2009 109

Table 72: Roche IVD Pipeline Product Portfolio 110

Table 73: Siemens Medical Solutions IVD Pipeline Product Portfolio 112

Table 74: Siemen's Merger and Acquisitions, IVD Market, 2007-2009 113

Table 75: Abbott Laboratories' Mergers and Acquisitions, IVD Market, 2007-2009 114

Table 76: Abbott Laboratories IVD Pipeline Products 114

Table 77: Beckman Coulter's Mergers and Acquisitions, IVD Market, 2007-2009 116

Table 78: Beckman Coulter, Inc. IVD Pipeline Products 117

Table 79: bioMerieux's Mergers and Acquisitions, IVD Market, 2007-2009 118

Table 80: bioMerieux Sa IVD Pipeline Products 118

Table 81: Ortho-Clinical Diagnostics, IVD Pipeline Products 119

Table 82: Becton Dickinson, Mergers and Acquisitions, IVD Market, 2007-2009 120

Table 83: Becton, Dickinson Inc. IVD Pipeline Portfolio 120

Table 84: Bio-Rad, Merger and Acquisitions, IVD Market, 2007-2009 121

Table 85: Inverness Medical Innovations, Inc., Mergers and Acquisitions, IVD Market, 2007-2009 122

Table 86: Inverness Medical Innovations IVD Pipeline Portfolio 123

Table 87: IVD Market, Global, Pipeline Products by Category, 2009 124

Table 88: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 125

Table 89: Infectious Immunology Market, Global, 2009 126

Table 90: Deals By Type, Global IVD Market, 2006-2009 131

Table 91: Key Deals, Global IVD Market, 2009 132

1.2 List of Figures

Figure 1: IVD Market, Global, Revenue ($m), 2002-2009 12

Figure 2: IVD Market, Global, Revenue ($m), 2009-2016 13

Figure 3: IVD Market, Global, Company Share (%),2008 14

Figure 4: Global In-vitro Devices: Key Market Trends 15

Figure 5: Global Laboratory Consolidation Landscape, 2005-2009 16

Figure 6: Global In Vitro Diagnostics: Key Technology Trends 17

Figure 7: Global In Vitro Diagnostics: Market Drivers and Restraints 19

Figure 8: List of Retail Clinics in the US and Diagnostic IVD Tests Offered 21

Figure 9: Clinical Chemistry Market, Global, Revenues ($m), 2002-2009 25

Figure 10: Clinical Chemistry Market, Global, Revenue ($m), 2009-2016 26

Figure 11: Clinical Chemistry Market, Global, Company Share (%),2008 27

Figure 12: Clinical Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002-2016 28

Figure 13: Immuno Chemistry Market, Global, Revenues ($m), 2002-2009 30

Figure 14: Immuno Chemistry Market, Global, Revenue ($m), 2009-2016 31

Figure 15: Immuno Chemistry Market, Global, Company Share (%),2008 32

Figure 16: Immuno Chemistry Market, Comparison of Top 10 Countries By Revenue, 2002-2016 33

Figure 17: Haematology Market, Global, Revenues ($m), 2002-2009 36

Figure 18: Haematology Market, Global, Revenue ($m), 2009-2016 37

Figure 19: Haematology Market, Global, Company Share (%),2008 38

Figure 20: Haematology Market, Comparison of Top 11 Countries By Revenue, 2002-2016 39

Figure 21: Histology and Cytology Market, Global, Revenue ($m), 2002-2009 41

Figure 22: Histology and Cytology Market, Global, Revenue ($m), 2009-2016 42

Figure 23: Histology and Cytology Market, Global, Company Share (%),2008 43

Figure 24: Histology and Cytology Market, Comparison of Top 10 Countries By Revenue,

2002-2016 44

Figure 25: Microbiology Culture Market, Global, Revenue ($m), 2002-2009 46

Figure 26: Microbiology Culture Market, Global, Revenue ($m), 2009-2016 47

Figure 27: Microbiology Market, Global, Company Share (%),2008 48

Figure 28: Microbiology Culture Market, Comparison of Top 10 Countries By Revenue,

2002-2016 49

Figure 29: Infectious Immunology Market, Global, Revenue ($m), 2002-2009 51

Figure 30: Infectious Immunology Market, Global, Revenue ($m), 2009-2016 52

Figure 31: Infectious Immunology Market, Global, Company Share (%),2008 53

Figure 32: Genetic Testing Market, Global, Revenue ($m), 2002-2009 55

Figure 33: Genetic Testing Market, Global, Revenue ($m), 2009-2016 56

Figure 34: Global Genetic Testing Market, Global, Company Share (%),2008 57

Figure 35: Genetic Testing Market, Comparison of Top 10 Countries By Revenue, 2002-2016 58

Figure 36: IVD Market, Global, Geographic Trends Analysis 61

Figure 37: IVD Market, US, Revenue ($m), 2002-2009 62

Figure 38: IVD Market, US, Revenue ($m), 2009-2016 63

Figure 39: IVD Market, Canada, Revenue ($m), 2002-2009 64

Figure 40: IVD Market, Canada, Revenue ($m), 2009-2016 65

Figure 41: IVD Market, The UK, Revenue ($m), 2002-2009 67

Figure 42: IVD Market, The UK, Revenue ($m), 2009-2016 68

Figure 43: IVD Market, Germany, Revenue ($m), 2002-2009 69

Figure 44: IVD Market, Germany, Revenue ($m), 2009-2016 70

Figure 45: IVD Market, France, Revenue ($m), 2002-2009 71

Figure 46: IVD Market, France, Revenue ($m), 2009-2016 73

Figure 47: IVD Market, Italy, Revenue ($m), 2002-2009 74

Figure 48: IVD Market, Italy, Revenue ($m), 2009-2016 75

Figure 49: IVD Market, Spain, Revenue ($m), 2002-2009 76

Figure 50: IVD Market, Spain, Revenue ($m), 2009-2016 77

Figure 51: IVD Market, Belgium, Revenue ($m), 2002-2009 78

Figure 52: IVD Market, Belgium, Revenue ($m), 2009-2016 79

Figure 53: IVD Market, The Netherlands, Revenue ($m), 2002-2009 80

Figure 54: IVD Market, The Netherlands, Revenue ($m), 2009-2016 81

Figure 55: IVD Market, Japan, Revenue ($m), 2002-2009 83

Figure 56: IVD Market, Japan, Revenue ($m), 2009-2016 84

Figure 57: IVD Market, China, Revenue ($m), 2002-2009 85

Figure 58: IVD Market, China, Revenue ($m), 2009-2016 86

Figure 59: IVD Market, India, Revenue ($m), 2002-2009 87

Figure 60: IVD Market, India, Revenue ($m), 2002-2009 88

Figure 61: IVD Market, Australia, Revenue ($m), 2002-2009 90

Figure 62: IVD Market, Australia, Revenue ($m), 2009-2016 91

Figure 63: IVD Market, Taiwan, Revenue ($m), 2002-2009 92

Figure 64: IVD Market, Taiwan, Revenue ($m), 2009-2016 93

Figure 65: IVD Market, Republic of Korea, Revenue ($m), 2002-2009 94

Figure 66: IVD Market, Republic of Korea, Revenue ($m), 2009-2016 95

Figure 67: IVD Market, Brazil, Revenue ($m), 2002-2009 97

Figure 68: IVD Market, Brazil, Revenue ($m), 2009-2016 98

Figure 69: IVD Market, Argentina, Revenue ($m), 2002-2009 99

Figure 70: IVD Market, Argentina, Revenue ($m), 2009-2016 100

Figure 71: IVD Market, Mexico, Revenue ($m), 2002-2009 101

Figure 72: IVD Market, Mexico, Revenue ($m), 2009-2016 102

Figure 73: IVD Market, Israel, Revenue ($m), 2002-2009 104

Figure 74: IVD Market, Israel, Revenue ($m), 2009-2016 105

Figure 75: IVD Market, South Africa, Revenue ($m), 2002-2009 106

Figure 76: IVD Market, South Africa, Revenue ($m), 2009-2016 107

Figure 77: IVD Market, Global, Pipeline Products Analysis by Category, 2009 124

Figure 78: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 125

Figure 79: Infectious Immunology Market, Global, 2009 126

Figure 80: Deals By Type, Global IVD Market, 2006-2009 131

Figure 81: Deals By Value and Volume, Global IVD Market, Value ($m), 2006-2009 132

Figure 82: GBI Research Methodology 145

Companies Mentioned

F. Hoffmann-La Roche Ltd

Siemens Medical Solutions USA, Inc.

Abbott Laboratories

Beckman Coulter, Inc

bioMerieux Sa

Ortho-Clinical Diagnostics

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc.

Inverness Medical Innovations, Inc

To order this report:

In Vitro Diagnostic Industry: The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
CareFusion, George Wein Announce Details of New Yo...
S
Actuaries Call on President and Congress to Adopt ...